IRIS

Improving gene therapy approaches for globoid cell leukodystrophy: pre-clinical testing of chimeric GALC enzymes with enhanced bioavailability in human neural and hematopoietic cells / Ricca, A; Freschi, M; Valeri, E; Unali, G; Cascino, F; Morena, F; Martino, S; Kajaste-Rudnitski, A; Gritti, A. - In: HUMAN GENE THERAPY. - ISSN 1043-0342. - 33:23-24(2022), p. A192.

Improving gene therapy approaches for globoid cell leukodystrophy: pre-clinical testing of chimeric GALC enzymes with enhanced bioavailability in human neural and hematopoietic cells

Valeri, E;Unali, G;Cascino, F;Gritti, A
2022-01-01
2022
Inglese
Human gene therapy
MARY ANN LIEBERT, INC
140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
33
23-24
A192
WOS:000899950600600
Esperti anonimi
Goal 3: Good health and well-being
No
9
info:eu-repo/semantics/conferenceObject
Improving gene therapy approaches for globoid cell leukodystrophy: pre-clinical testing of chimeric GALC enzymes with enhanced bioavailability in human neural and hematopoietic cells / Ricca, A; Freschi, M; Valeri, E; Unali, G; Cascino, F; Morena, F; Martino, S; Kajaste-Rudnitski, A; Gritti, A. - In: HUMAN GENE THERAPY. - ISSN 1043-0342. - 33:23-24(2022), p. A192.
none
274
4 Contributo in Atti di Convegno (Proceeding)::4.2 Abstract in Atti di convegno
Ricca, A; Freschi, M; Valeri, E; Unali, G; Cascino, F; Morena, F; Martino, S; Kajaste-Rudnitski, A; Gritti, A
4.2 Abstract in Atti di convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/173096
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact